Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Petco Health & Wellness Company (WOOF) over the last 5 years, with Q4 2025 value amounting to $237.4 million.

  • Petco Health & Wellness Company's Cash & Equivalents rose 10348.23% to $237.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $237.4 million, marking a year-over-year increase of 10348.23%. This contributed to the annual value of $165.8 million for FY2025, which is 3215.23% up from last year.
  • Latest data reveals that Petco Health & Wellness Company reported Cash & Equivalents of $237.4 million as of Q4 2025, which was up 10348.23% from $188.7 million recorded in Q3 2025.
  • Petco Health & Wellness Company's Cash & Equivalents' 5-year high stood at $237.4 million during Q4 2025, with a 5-year trough of $89.7 million in Q2 2024.
  • Its 5-year average for Cash & Equivalents is $161.8 million, with a median of $157.3 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 3976.38% in 2024, then skyrocketed by 10348.23% in 2025.
  • Quarter analysis of 5 years shows Petco Health & Wellness Company's Cash & Equivalents stood at $221.5 million in 2021, then tumbled by 32.85% to $148.7 million in 2022, then dropped by 6.02% to $139.8 million in 2023, then dropped by 16.53% to $116.7 million in 2024, then soared by 103.48% to $237.4 million in 2025.
  • Its Cash & Equivalents stands at $237.4 million for Q4 2025, versus $188.7 million for Q3 2025 and $133.3 million for Q2 2025.